Mounjaro 2.5mg vs 5mg weight loss: what to expect at each dose

Step 1, what the 2.5mg pen is actually for

Tirzepatide works by activating two gut-hormone receptors simultaneously, the GIP and GLP-1 pathways, slowing gastric emptying and reducing appetite signals. At 2.5mg, this mechanism is live but deliberately restrained. The prescribing schedule (confirmed in the NHS tirzepatide patient guide) starts here specifically to reduce the nausea and digestive disruption that can otherwise push people to stop treatment entirely.

In practice, many people notice a modest reduction in hunger during their first four weeks, and some see a small drop in weight. That is a welcome side effect of the starter dose, not the design. The 2.5mg pen's job is adjustment. Expecting a dramatic result from it is a bit like expecting the warm-up to be the race. You can read more about what that first month looks like, including realistic expectations, on our dedicated page covering how the 2.5mg dose contributes to weight loss.

Side effects here are usually mild: a little nausea after eating, perhaps some constipation or loose stools for a week or two. They tend to settle before the four-week mark. If they do not, your prescriber needs to know before any dose change.

Step 2, moving to 5mg and where weight loss takes hold

The 5mg dose is where the majority of patients first notice a clear shift in appetite. Portions that once felt normal begin to feel like too much. The urge to snack between meals quietly disappears for many people. This is the first dose at which tirzepatide's dual mechanism is operating with real effect.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults over 72 weeks and found average weight reductions around 20% at the highest doses. Those outcomes were built on a foundation of correct titration, spending enough time at each dose for the body to adapt. Jumping to a higher strength too quickly does not accelerate results; it tends to increase side effects.

At 5mg you are also more likely to notice the GI effects more clearly than at 2.5mg: nausea is typically at its highest in the first week or two after any dose step. Staying well hydrated, eating smaller portions, and keeping meals lower in fat helps most people through it. Our Mounjaro 5mg weight loss page covers what patients commonly experience during this phase.

Comparing 2.5mg and 5mg side by side

The table below summarises the key factual differences. Where results figures appear, they reflect clinical trial data from SURMOUNT-1 and are population averages, individual outcomes vary.

Source: NICE technology appraisal TA1026 (tirzepatide); SURMOUNT-1, NEJM.

Which dose is right for you, and how that decision gets made

Neither dose is inherently better in isolation. The question is always: where are you in the schedule, and is this the right moment to move? If you are tolerating 2.5mg well after four weeks, 5mg is the natural next step. If side effects at 5mg are significant, your prescriber may suggest staying there longer rather than pressing on to 7.5mg on a calendar schedule alone.

NICE TA1026 recommends tirzepatide for adults with a BMI of 35 or above alongside at least one weight-related health condition, with lower BMI thresholds applying for some ethnic backgrounds under UK guidance. Private prescribing through a regulated pharmacy follows the licensed eligibility criteria (BMI of 30 or above, or 27 or above with a qualifying condition) and a prescriber weighs the whole clinical picture, not the BMI figure alone.

At nume, every dose increase goes through a fresh clinical review. A real clinician reads your progress notes and evidence before your next pen is approved. If you are weighing up whether to start, or wondering whether to continue beyond 5mg, our free consultation is the place to begin, check your eligibility and speak to our prescribing team. You can also read about how Mounjaro 10mg approaches weight loss differently as the dose increases on our overview page.